✦ LIBER ✦

Combination chemotherapy with cisplatin and irinotecan in patients with adenocarcinoma of the small intestine

✍ Scribed by Makiko Ono; Kuniaki Shirao; Atsuo Takashima; Chigusa Morizane; Natsuko Okita; Daisuke Takahari; Yoshinori Hirashima; Takako Eguchi-Nakajima; Ken Kato; Tetsuya Hamaguchi; Yasuhide Yamada; Yasuhiro Shimada

Publisher: Springer
Year: 2008
Tongue: English
Weight: 174 KB
Volume: 11
Category: Article
ISSN: 1436-3291
DOI: 10.1007/s10120-008-0484-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination chemotherapy with irinotecan

Combination chemotherapy with irinotecan and cisplatin in pretreated patients with unresectable or recurrent gastric cancer

✍ Shinya Ueda; Shuichi Hironaka; Narikazu Boku; Akira Fukutomi; Takayuki Yoshino; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 341 KB

Combination chemotherapy with irinotecan

Combination chemotherapy with irinotecan and cisplatin as second-line treatment for small cell lung cancer

✍ Jie Luo; Ying Xu; Songwen Zhou; Aiwu Li; Di Zheng; Jianfang Xu; Caicun Zhou 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 278 KB

Phase I studies of imatinib mesylate com

Phase I studies of imatinib mesylate combined with cisplatin and irinotecan in patients with small cell lung carcinoma

✍ Faye M. Johnson; Lee M. Krug; Hai T. Tran; Stephanie Shoaf; Victor G. Prieto; Ph 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 329 KB 👁 2 views

Comparison of combination chemotherapy w

Comparison of combination chemotherapy with irinotecan and cisplatin regimen administered every 2 or 4

✍ Takeshi Sakamoto; Hirofumi Yasui; Narikazu Boku; Yusuke Onozawa; Shuichi Hironak 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 183 KB

Two patients with ovarian cancer refract

Two patients with ovarian cancer refractory to cisplatin-based chemotherapy managed by a new combination chemotherapy with irinotecan hydrochloride and mitomycin-C

✍ Ken Takizawa; Yoh-ichi Satow; Yoshio Kato; Takashi Kawana 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 413 KB

Renal function following combination che

Renal function following combination chemotherapy with ifosfamide and cisplatin in patients with osteogenic sarcoma

✍ Arndt, Carola; Morgenstern, Bruce; Hawkins, Douglas; Wilson, David; Liedtke, Rob 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 2 views

## Background: Ifosfamide and cisplatin are active agents that are currently used in the treatment of osteosarcoma. nephrotoxicity has been reported following their use in combination and alone. this study evaluates renal function in children and adolescents (median age 16 years) at least 3 months